PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+5.38%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.64B
AUM Growth
-$53.3M
(-2%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
36.54%
Holding
1,168
New
94
Increased
480
Reduced
555
Closed
36
Top Buys
| 1 |
Apple
AAPL
|
$4.55M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$1.79M |
| 3 |
ConocoPhillips
COP
|
$1.73M |
| 4 |
Insmed
INSM
|
$1.69M |
| 5 |
Super Micro Computer
SMCI
|
$1.63M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$51.6M |
| 2 |
Microsoft
MSFT
|
$20.2M |
| 3 |
Broadcom
AVGO
|
$9.75M |
| 4 |
Meta Platforms (Facebook)
META
|
$6.72M |
| 5 |
Amazon
AMZN
|
$5.69M |
Sector Composition
| 1 | Technology | 43.4% |
| 2 | Healthcare | 11.97% |
| 3 | Consumer Discretionary | 10.33% |
| 4 | Communication Services | 9.11% |
| 5 | Financials | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Sabra Healthcare REIT
SBRA
$4.58B
| $201K | 0.01% |
10,779
+167
| +2% | +$3.11K |
|
|
X
1052
DELISTED
US Steel
X
| $200K | 0.01% |
5,672
-128
| -2% | -$4.52K |
|
|
VERV
1053
DELISTED
Verve Therapeutics
VERV
| $200K | 0.01% |
41,391
+13,477
| +48% | +$65.2K |
|
1054
First Industrial Realty Trust
FR
$6.89B
| $200K | 0.01% |
+3,576
| New | +$200K |
|
1055
Popular Inc
BPOP
$8.59B
| $200K | 0.01% |
+1,995
| New | +$200K |
|
1056
Macerich
MAC
$4.68B
| $199K | 0.01% |
10,916
+537
| +5% | +$9.8K |
|
1057
4D Molecular Therapeutics
FDMT
$309M
| $196K | 0.01% |
18,142
+180
| +1% | +$1.95K |
|
1058
Gerdau
GGB
$6.15B
| $195K | 0.01% |
55,620
-5,025
| -8% | -$17.6K |
|
1059
Ocular Therapeutix
OCUL
$2.21B
| $195K | 0.01% |
22,357
-20,825
| -48% | -$181K |
|
1060
89bio
ETNB
$1.28B
| $191K | 0.01% |
25,843
-1,257
| -5% | -$9.3K |
|
1061
Amneal Pharmaceuticals
AMRX
$3B
| $190K | 0.01% |
22,858
+336
| +1% | +$2.8K |
|
1062
Altimmune
ALT
$314M
| $190K | 0.01% |
30,954
-9,807
| -24% | -$60.2K |
|
1063
Core Laboratories
CLB
$585M
| $188K | 0.01% |
+10,161
| New | +$188K |
|
1064
American Airlines Group
AAL
$8.49B
| $187K | 0.01% |
16,649
+6,353
| +62% | +$71.4K |
|
1065
Scholar Rock
SRRK
$3.12B
| $187K | 0.01% |
23,312
-1,668
| -7% | -$13.4K |
|
1066
Equinox Gold
EQX
$7.01B
| $181K | 0.01% |
29,793
+2,924
| +11% | +$17.8K |
|
1067
Apple Hospitality REIT
APLE
$3.09B
| $179K | 0.01% |
12,024
+38
| +0.3% | +$564 |
|
1068
BGC Group
BGC
$4.74B
| $178K | 0.01% |
19,430
+185
| +1% | +$1.7K |
|
1069
Regenxbio
RGNX
$476M
| $177K | 0.01% |
16,858
-3,749
| -18% | -$39.3K |
|
1070
Allogene Therapeutics
ALLO
$246M
| $175K | 0.01% |
62,634
-13,526
| -18% | -$37.9K |
|
1071
Select Water Solutions
WTTR
$913M
| $175K | 0.01% |
15,716
-6,504
| -29% | -$72.4K |
|
1072
ProPetro Holding
PUMP
$514M
| $174K | 0.01% |
22,665
-9,459
| -29% | -$72.5K |
|
|
NGD
1073
New Gold Inc
NGD
$4.86B
| $170K | 0.01% |
59,103
-644
| -1% | -$1.86K |
|
1074
Celcuity
CELC
$2.31B
| $168K | 0.01% |
+11,267
| New | +$168K |
|
1075
C4 Therapeutics
CCCC
$190M
| $162K | 0.01% |
28,436
-5,713
| -17% | -$32.6K |
|